APO Research
Talk to an analyst

APO RESEARCH · REPORT

Felodipine Extended-Release Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Felodipine Extended-Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025194 pages

Choose your research edition.

Industry ResearchFelodipine Extended-Release Tablets Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Felodipine Extended-Release Tablets Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Felodipine Extended-Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Felodipine Extended-Release Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Felodipine Extended-Release Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Felodipine Extended-Release Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Felodipine Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Felodipine Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Felodipine Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Felodipine Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Felodipine Extended-Release Tablets include By-Health, CSPC, Zhejiang Cheng Yi Pharmaceutical, Watsons, Schiff, Pfizer, Movefree, KAL and Doppelherz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Felodipine Extended-Release Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Felodipine Extended-Release Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Felodipine Extended-Release Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Felodipine Extended-Release Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Felodipine Extended-Release Tablets Segment by Company

By-Health

CSPC

Zhejiang Cheng Yi Pharmaceutical

Watsons

Schiff

Pfizer

Movefree

KAL

Doppelherz

Blackmores

AdvaCare

Felodipine Extended-Release Tablets Segment by Type

Tablets

Capsules

Felodipine Extended-Release Tablets Segment by Application

Hospital

Clinic

Pharmacy

Felodipine Extended-Release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felodipine Extended-Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Felodipine Extended-Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felodipine Extended-Release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Felodipine Extended-Release Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Felodipine Extended-Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Felodipine Extended-Release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Felodipine Extended-Release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Felodipine Extended-Release Tablets Industry Trends Table 2. Felodipine Extended-Release Tablets Industry Drivers Table 3. Felodipine Extended-Release Tablets Industry Opportunities and Challenges Table 4. Felodipine Extended-Release Tablets Industry Restraints Table 5. Global Felodipine Extended-Release Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Felodipine Extended-Release Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Felodipine Extended-Release Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Felodipine Extended-Release Tablets Sales Market Share by Manufacturers Table 9. Global Felodipine Extended-Release Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Felodipine Extended-Release Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Felodipine Extended-Release Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Felodipine Extended-Release Tablets Manufacturers, Product Type & Application Table 13. Global Felodipine Extended-Release Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Felodipine Extended-Release Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets Table 17. Major Manufacturers of Capsules Table 18. Global Felodipine Extended-Release Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Felodipine Extended-Release Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Felodipine Extended-Release Tablets Sales Market Share by Type (2021-2026) Table 22. Global Felodipine Extended-Release Tablets Sales Market Share by Type (2027-2032) Table 23. Global Felodipine Extended-Release Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Felodipine Extended-Release Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Felodipine Extended-Release Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Pharmacy Table 31. Global Felodipine Extended-Release Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Felodipine Extended-Release Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Felodipine Extended-Release Tablets Sales Market Share by Application (2021-2026) Table 35. Global Felodipine Extended-Release Tablets Sales Market Share by Application (2027-2032) Table 36. Global Felodipine Extended-Release Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Felodipine Extended-Release Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Felodipine Extended-Release Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Felodipine Extended-Release Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Felodipine Extended-Release Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Felodipine Extended-Release Tablets Sales Market Share by Region (2021-2026) Table 44. Global Felodipine Extended-Release Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Felodipine Extended-Release Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Felodipine Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Felodipine Extended-Release Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Felodipine Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Felodipine Extended-Release Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Felodipine Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Felodipine Extended-Release Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Felodipine Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Felodipine Extended-Release Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Felodipine Extended-Release Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Felodipine Extended-Release Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Felodipine Extended-Release Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Felodipine Extended-Release Tablets Revenue Market Share by Region (2027-2032) Table 63. By-Health Company Information Table 64. By-Health Business Overview Table 65. By-Health Felodipine Extended-Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. By-Health Felodipine Extended-Release Tablets Product Portfolio Table 67. By-Health Recent Development Table 68. CSPC Company Information Table 69. CSPC Business Overview Table 70. CSPC Felodipine Extended-Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. CSPC Felodipine Extended-Release Tablets Product Portfolio Table 72. CSPC Recent Development Table 73. Zhejiang Cheng Yi Pharmaceutical Company Information Table 74. Zhejiang Cheng Yi Pharmaceutical Business Overview Table 75. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolio Table 77. Zhejiang Cheng Yi Pharmaceutical Recent Development Table 78. Watsons Company Information Table 79. Watsons Business Overview Table 80. Watsons Felodipine Extended-Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Watsons Felodipine Extended-Release Tablets Product Portfolio Table 82. Watsons Recent Development Table 83. Schiff Company Information Table 84. Schiff Business Overview Table 85. Schiff Felodipine Extended-Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Schiff Felodipine Extended-Release Tablets Product Portfolio Table 87. Schiff Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Felodipine Extended-Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Pfizer Felodipine Extended-Release Tablets Product Portfolio Table 92. Pfizer Recent Development Table 93. Movefree Company Information Table 94. Movefree Business Overview Table 95. Movefree Felodipine Extended-Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Movefree Felodipine Extended-Release Tablets Product Portfolio Table 97. Movefree Recent Development Table 98. KAL Company Information Table 99. KAL Business Overview Table 100. KAL Felodipine Extended-Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. KAL Felodipine Extended-Release Tablets Product Portfolio Table 102. KAL Recent Development Table 103. Doppelherz Company Information Table 104. Doppelherz Business Overview Table 105. Doppelherz Felodipine Extended-Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Doppelherz Felodipine Extended-Release Tablets Product Portfolio Table 107. Doppelherz Recent Development Table 108. Blackmores Company Information Table 109. Blackmores Business Overview Table 110. Blackmores Felodipine Extended-Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Blackmores Felodipine Extended-Release Tablets Product Portfolio Table 112. Blackmores Recent Development Table 113. AdvaCare Company Information Table 114. AdvaCare Business Overview Table 115. AdvaCare Felodipine Extended-Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. AdvaCare Felodipine Extended-Release Tablets Product Portfolio Table 117. AdvaCare Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Felodipine Extended-Release Tablets Distributors List Table 121. Felodipine Extended-Release Tablets Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Felodipine Extended-Release Tablets Product Image Figure 2. Global Felodipine Extended-Release Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Felodipine Extended-Release Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Felodipine Extended-Release Tablets Sales (2021-2032) & (K Units) Figure 5. Global Felodipine Extended-Release Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Felodipine Extended-Release Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets Image Figure 9. Capsules Image Figure 10. Global Felodipine Extended-Release Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Felodipine Extended-Release Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Felodipine Extended-Release Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Felodipine Extended-Release Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Felodipine Extended-Release Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Pharmacy Image Figure 19. Global Felodipine Extended-Release Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Felodipine Extended-Release Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Felodipine Extended-Release Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Felodipine Extended-Release Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Felodipine Extended-Release Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Felodipine Extended-Release Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Felodipine Extended-Release Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Felodipine Extended-Release Tablets Sales Market Share by Country (2021-2032) Figure 39. China Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Felodipine Extended-Release Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Felodipine Extended-Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Felodipine Extended-Release Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Felodipine Extended-Release Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Felodipine Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Felodipine Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Felodipine Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Felodipine Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Felodipine Extended-Release Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Felodipine Extended-Release Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • By-Health
  • CSPC
  • Zhejiang Cheng Yi Pharmaceutical
  • Watsons
  • Schiff
  • Pfizer
  • Movefree
  • KAL
  • Doppelherz
  • Blackmores
  • AdvaCare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Felodipine Extended-Release Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Felodipine Extended-Release Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Felodipine Extended-Release Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Felodipine Extended-Release Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Felodipine Extended-Release Tablets Market Dynamics
  1. 2.1 Felodipine Extended-Release Tablets Industry Trends
  2. 2.2 Felodipine Extended-Release Tablets Industry Drivers
  3. 2.3 Felodipine Extended-Release Tablets Industry Opportunities and Challenges
  4. 2.4 Felodipine Extended-Release Tablets Industry Restraints
3 Felodipine Extended-Release Tablets Market by Manufacturers
  1. 3.1 Global Felodipine Extended-Release Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Felodipine Extended-Release Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Felodipine Extended-Release Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Felodipine Extended-Release Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Felodipine Extended-Release Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Felodipine Extended-Release Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Felodipine Extended-Release Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Felodipine Extended-Release Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Felodipine Extended-Release Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Felodipine Extended-Release Tablets Tier 1, Tier 2, and Tier 3
4 Felodipine Extended-Release Tablets Market by Type
  1. 4.1 Felodipine Extended-Release Tablets Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Capsules
  4. 4.2 Global Felodipine Extended-Release Tablets Sales by Type
  5. 4.2.1 Global Felodipine Extended-Release Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Felodipine Extended-Release Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Felodipine Extended-Release Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Felodipine Extended-Release Tablets Revenue by Type
  9. 4.3.1 Global Felodipine Extended-Release Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Felodipine Extended-Release Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2021-2032)
5 Felodipine Extended-Release Tablets Market by Application
  1. 5.1 Felodipine Extended-Release Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Pharmacy
  5. 5.2 Global Felodipine Extended-Release Tablets Sales by Application
  6. 5.2.1 Global Felodipine Extended-Release Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Felodipine Extended-Release Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Felodipine Extended-Release Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Felodipine Extended-Release Tablets Revenue by Application
  10. 5.3.1 Global Felodipine Extended-Release Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Felodipine Extended-Release Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2021-2032)
6 Global Felodipine Extended-Release Tablets Sales by Region
  1. 6.1 Global Felodipine Extended-Release Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Felodipine Extended-Release Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Felodipine Extended-Release Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Felodipine Extended-Release Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Felodipine Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Felodipine Extended-Release Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Felodipine Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Felodipine Extended-Release Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Felodipine Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Felodipine Extended-Release Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Felodipine Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Felodipine Extended-Release Tablets Revenue by Region
  1. 7.1 Global Felodipine Extended-Release Tablets Revenue by Region
  2. 7.1.1 Global Felodipine Extended-Release Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Felodipine Extended-Release Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Felodipine Extended-Release Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Felodipine Extended-Release Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Felodipine Extended-Release Tablets Revenue (2021-2032)
  8. 7.2.2 North America Felodipine Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Felodipine Extended-Release Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Felodipine Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Felodipine Extended-Release Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Felodipine Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Felodipine Extended-Release Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Felodipine Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 By-Health
  2. 8.1.1 By-Health Company Information
  3. 8.1.2 By-Health Business Overview
  4. 8.1.3 By-Health Felodipine Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 By-Health Felodipine Extended-Release Tablets Product Portfolio
  6. 8.1.5 By-Health Recent Developments
  7. 8.2 CSPC
  8. 8.2.1 CSPC Company Information
  9. 8.2.2 CSPC Business Overview
  10. 8.2.3 CSPC Felodipine Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CSPC Felodipine Extended-Release Tablets Product Portfolio
  12. 8.2.5 CSPC Recent Developments
  13. 8.3 Zhejiang Cheng Yi Pharmaceutical
  14. 8.3.1 Zhejiang Cheng Yi Pharmaceutical Company Information
  15. 8.3.2 Zhejiang Cheng Yi Pharmaceutical Business Overview
  16. 8.3.3 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolio
  18. 8.3.5 Zhejiang Cheng Yi Pharmaceutical Recent Developments
  19. 8.4 Watsons
  20. 8.4.1 Watsons Company Information
  21. 8.4.2 Watsons Business Overview
  22. 8.4.3 Watsons Felodipine Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Watsons Felodipine Extended-Release Tablets Product Portfolio
  24. 8.4.5 Watsons Recent Developments
  25. 8.5 Schiff
  26. 8.5.1 Schiff Company Information
  27. 8.5.2 Schiff Business Overview
  28. 8.5.3 Schiff Felodipine Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Schiff Felodipine Extended-Release Tablets Product Portfolio
  30. 8.5.5 Schiff Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Felodipine Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Felodipine Extended-Release Tablets Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Movefree
  38. 8.7.1 Movefree Company Information
  39. 8.7.2 Movefree Business Overview
  40. 8.7.3 Movefree Felodipine Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Movefree Felodipine Extended-Release Tablets Product Portfolio
  42. 8.7.5 Movefree Recent Developments
  43. 8.8 KAL
  44. 8.8.1 KAL Company Information
  45. 8.8.2 KAL Business Overview
  46. 8.8.3 KAL Felodipine Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 KAL Felodipine Extended-Release Tablets Product Portfolio
  48. 8.8.5 KAL Recent Developments
  49. 8.9 Doppelherz
  50. 8.9.1 Doppelherz Company Information
  51. 8.9.2 Doppelherz Business Overview
  52. 8.9.3 Doppelherz Felodipine Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Doppelherz Felodipine Extended-Release Tablets Product Portfolio
  54. 8.9.5 Doppelherz Recent Developments
  55. 8.10 Blackmores
  56. 8.10.1 Blackmores Company Information
  57. 8.10.2 Blackmores Business Overview
  58. 8.10.3 Blackmores Felodipine Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Blackmores Felodipine Extended-Release Tablets Product Portfolio
  60. 8.10.5 Blackmores Recent Developments
  61. 8.11 AdvaCare
  62. 8.11.1 AdvaCare Company Information
  63. 8.11.2 AdvaCare Business Overview
  64. 8.11.3 AdvaCare Felodipine Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AdvaCare Felodipine Extended-Release Tablets Product Portfolio
  66. 8.11.5 AdvaCare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Felodipine Extended-Release Tablets Value Chain Analysis
  2. 9.1.1 Felodipine Extended-Release Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Felodipine Extended-Release Tablets Production Mode & Process
  6. 9.2 Felodipine Extended-Release Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Felodipine Extended-Release Tablets Distributors
  9. 9.2.3 Felodipine Extended-Release Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst